RecruitingObservationalLast updated Jan 5, 2024

Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study

Overview

ClinicalTrials.gov ID: NCT06189898
Lead Sponsor: Sebastian ZschaeckOTHER
Brief Summary: This trial on biomarker validation investigates the use of innovative re-staging FDG-PET parameters to detect highly chemoradiation (CRT) sensitive squamous cell carcinomas of the esophagus (SCEC) at the end of preoperative or definitive CRT.
Study Type: Observational

Status

Study Record Dates

NCT04759235Unknown status

Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC

NCT00833625Completed

FDG-PET-CT and Biomarkers in Esophageal Cancer

NCT05855278Completed

The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients

NCT03029793Unknown status

Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer

NCT00004867Completed

Positron Emission Tomography in Determining Stage of Esophageal Cancer

NCT00002930Completed

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery